SZSE: 301246 - Hubei Hongyuan Pharmaceutical Technology Co., Ltd.

Yield per half year: -50.14%
Sector: Healthcare

Reporting Hubei Hongyuan Pharmaceutical Technology Co., Ltd.

Capitalization

IFRS
Reporting Annual
5 year average CAGR 5


Share

IFRS
Reporting Annual Quarterly
2023 2024 LTM 5 year average CAGR 5
EPS 0.218
Цена акции ао 30.99 10.72 10.72


Efficiency

IFRS
Reporting Annual
2023 2024 LTM Industry average 5 year average CAGR 5
ROS, % 0 0 0 23.77
Operation Margin, % 0 0 0 0.00


Coefficients

IFRS
Reporting Annual
2023 2024 LTM Industry average 5 year average CAGR 5
P/FCF
0 0 0 0.00
E/P
0 0 0 0.04
EV/Ebit
0 0
EV/S
0 0 0 9.50
EV/FCF
0 0 0.00
Debt/EBITDA
0 0 0 0.59
Netdebt/Ebitda
0 0 0 0.00
Debt/Ratio
0 0 0 0.00
Debt/Equity
0 0 0 0.00
Debt/Net Income
0 0 0 0.75
Бета
0 -2.26 -2.26 -1.90
Индекс Альтмана
0 0 0 0.00


Dividends

IFRS
Reporting Annual Quarterly
2023 Industry average 5 year average CAGR 5
Дивиденд
0.1
Див доход, ао, %
0.3227 1.17


Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe

Other

IFRS
Reporting Annual
2023 2024 CAGR 5
Персонал, чел
2164 2164